OmniMD AI Scribe vs Sporo AI Scribe

Sporo AI Scribe is a 2024 start-up that calls itself an AI lab. It ships web, iOS and Android apps with a browser extension and an API, and its vendor-run arXiv preprint compares recall, precision and F1 against GPT-4o mini on de-identified transcripts. The preprint is not peer reviewed. PitchBook lists about $1.1M raised and six employees, Elion lists one, and the site offers a demo form in place of a price. A clinician or small group that wants to build on an API is the Sporo buyer. OmniMD is the older vendor: LinkedIn puts its founding at 2001 and its headcount at 201 to 500, the vendor says the clinician approves every note before it is final, and the scribe page carries a free-trial button. On company age and size Sporo is the smaller bet. OmniMD's 98.65% accuracy figure is the vendor's own claim, with no study or method given, and neither vendor cites an independent study. A multi-clinic cardiology group that wants an established vendor will find it in OmniMD.